Home|Journals|Articles by Year|Audio Abstracts
 

Mini Review

J App Pharm Sci. 2018; 8(5): 174-178


Role of MicroRNAs in hepatic fibrosis progression

Ezhilarasan Devaraj.




Abstract

Acute liver injury induced deviation in liver architecture are transient and often reversible. While chronic liver diseases lead to progressive net accumulation of extracellular matrix (ECM) in the liver leading to hepatic fibrosis. If left untreated, hepatic fibrosis can lead to cirrhosis and consequence of organ failure and death. Hepatic stellate cells (HSCs) activation plays a significant role in the pathogenesis of hepatic fibrosis. MicroRNAs are short, non-coding, single-stranded RNA and their modulation upon chronic liver injury are said to involve in the activation and proliferation of HSCs that causes synthesis and accumulation of the enormous amount of ECM proteins by HSCs in liver consequently hepatic fibrosis. This review summarizes the modulation of key miRNAs pertaining to hepatic fibrosis.

Key words: Hepatic stellate cells, extracellular matrix, miRNAs, liver fibrosis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.